Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) shares crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $3.24 and traded as high as $3.68. Hypera shares last traded at $3.68, with a volume of 178 shares.
Hypera Stock Performance
The business’s 50 day simple moving average is $3.25 and its two-hundred day simple moving average is $3.75. The company has a quick ratio of 1.41, a current ratio of 1.81 and a debt-to-equity ratio of 0.68.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- 3 Dividend Kings To Consider
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Why is the Ex-Dividend Date Significant to Investors?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
